Page last updated: 2024-08-24

thiazolyl blue and Thyroid Neoplasms

thiazolyl blue has been researched along with Thyroid Neoplasms in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (22.22)18.2507
2000's6 (66.67)29.6817
2010's0 (0.00)24.3611
2020's1 (11.11)2.80

Authors

AuthorsStudies
Sabra, MM; Sherman, EJ; Tuttle, RM; Yeh, T; Yeung, M1
Bufo, P; Cignarelli, M; Costantino, E; Fabiano, A; Farese, A; Landriscina, M; Maddalena, F; Piscazzi, A1
Chung, HK; Han, HJ; Hwang, ES; Jung, NC; Kim, D; Kim, DW; Kim, H; Kim, JM; Ku, BJ; Park, KC; Ro, HK; Shong, M; Song, JH; Suh, JM; Yi, YW1
Böckmann, M; Cranston, AN; Dahmen, U; Drosten, M; Hilken, G; Mise, N; Ponder, BA; Pützer, BM; Rödicker, F1
Asa, SL; Ezzat, S; Liu, W; St Bernard, R; Winer, D; Zheng, L1
Brabant, G; Jakubcakova, V; Kant, S; Kremenevskaja, N; Rao, AS; Resch, J; von Wasielewski, R1
Delmore, JE; Hayden, P; Kotoula, V; McMillin, DW; McMullan, C; Mitsiades, CS; Mitsiades, N; Negri, J; Poulaki, V1
Ishimura, H; Sasaki, F; Takada, N; Uchino, J1
Asaga, T; Kawahara, S; Osawa, Y; Yanoma, S; Yoshida, A1

Other Studies

9 other study(ies) available for thiazolyl blue and Thyroid Neoplasms

ArticleYear
Structural Doubling Time Predicts Overall Survival in Patients with Medullary Thyroid Cancer in Patients with Rapidly Progressive Metastatic Medullary Thyroid Cancer Treated with Molecular Targeted Therapies.
    Thyroid : official journal of the American Thyroid Association, 2020, Volume: 30, Issue:8

    Topics: Adolescent; Adult; Aged; Calcitonin; Carcinoembryonic Antigen; Carcinoma, Neuroendocrine; Cell Proliferation; Disease Progression; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Liver Neoplasms; Lung Neoplasms; Magnetic Resonance Imaging; Male; Middle Aged; Molecular Targeted Therapy; Neoplasm Metastasis; Prognosis; Retrospective Studies; Tetrazolium Salts; Thiazoles; Thyroid Neoplasms; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Young Adult

2020
Targeting epidermal growth factor receptor 1 signaling in human thyroid-stimulating hormone-independent thyroid carcinoma FRO cells results in a more chemosensitive and less angiogenic phenotype.
    Thyroid : official journal of the American Thyroid Association, 2009, Volume: 19, Issue:6

    Topics: Antineoplastic Agents; Blotting, Western; Cell Differentiation; Cell Line, Tumor; Cell Movement; Cell Survival; Down-Regulation; Drug Resistance, Neoplasm; ErbB Receptors; Humans; Microscopy, Confocal; Neovascularization, Pathologic; Phenotype; RNA, Neoplasm; S Phase; Signal Transduction; Tetrazolium Salts; Thiazoles; Thyroid Neoplasms; Thyrotropin

2009
Gadd45gamma expression is reduced in anaplastic thyroid cancer and its reexpression results in apoptosis.
    The Journal of clinical endocrinology and metabolism, 2003, Volume: 88, Issue:8

    Topics: Adenoviridae; Animals; Apoptosis; Blotting, Northern; Blotting, Western; Carcinoma; GADD45 Proteins; Gene Expression Regulation, Neoplastic; Genes, p53; Genetic Therapy; Humans; Immunohistochemistry; Indicators and Reagents; Intracellular Signaling Peptides and Proteins; Mice; Mice, Nude; Neoplasm Transplantation; Protein Biosynthesis; Proteins; RNA, Neoplasm; Tetrazolium Salts; Thiazoles; Thyroid Neoplasms; Transduction, Genetic; Transplantation, Heterologous; Tumor Cells, Cultured

2003
Role of MEN2A-derived RET in maintenance and proliferation of medullary thyroid carcinoma.
    Journal of the National Cancer Institute, 2004, Aug-18, Volume: 96, Issue:16

    Topics: Adenoviridae; Animals; Bromodeoxyuridine; Carcinoma, Medullary; Cell Division; Cell Line, Tumor; Cell Survival; Gene Expression Regulation, Neoplastic; Genetic Vectors; Humans; Mice; Mice, Transgenic; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Multiple Endocrine Neoplasia Type 2a; Oncogene Proteins; Oncogene Proteins, Fusion; Phosphorylation; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-ret; Receptor Protein-Tyrosine Kinases; Signal Transduction; Tetrazolium Salts; Thiazoles; Thyroid Neoplasms

2004
Fibroblast growth factor receptors as molecular targets in thyroid carcinoma.
    Endocrinology, 2005, Volume: 146, Issue:3

    Topics: Adenoviridae; Animals; Blotting, Western; Carcinoma; Cell Differentiation; Cell Line; Cell Line, Tumor; Cell Proliferation; Coloring Agents; Dose-Response Relationship, Drug; Female; Humans; Immunohistochemistry; Mice; Mice, SCID; Neoplasm Transplantation; Protein-Tyrosine Kinases; Pyrimidines; Receptor Protein-Tyrosine Kinases; Receptor, Fibroblast Growth Factor, Type 1; Receptor, Fibroblast Growth Factor, Type 2; Receptor, Fibroblast Growth Factor, Type 3; Receptor, Fibroblast Growth Factor, Type 4; Receptors, Fibroblast Growth Factor; Signal Transduction; Tetrazolium Salts; Thiazoles; Thyroid Gland; Thyroid Neoplasms; Time Factors

2005
Wnt/beta-catenin signaling mediates antineoplastic effects of imatinib mesylate (gleevec) in anaplastic thyroid cancer.
    The Journal of clinical endocrinology and metabolism, 2006, Volume: 91, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Benzamides; beta Catenin; Blotting, Western; Carcinoma; Caspase 3; Caspase 7; Caspases; Cell Proliferation; Collagen; Drug Combinations; Fluorescent Antibody Technique; Genes, Reporter; Humans; Imatinib Mesylate; Immunoprecipitation; Laminin; Luciferases; Microscopy, Confocal; Oligonucleotide Array Sequence Analysis; Piperazines; Proteoglycans; Pyrimidines; Signal Transduction; Tetrazolium Salts; Thiazoles; Thymidine; Thyroid Neoplasms; Transfection; Tumor Cells, Cultured

2006
Bcl-2 overexpression in thyroid carcinoma cells increases sensitivity to Bcl-2 homology 3 domain inhibition.
    The Journal of clinical endocrinology and metabolism, 2007, Volume: 92, Issue:12

    Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; BH3 Interacting Domain Death Agonist Protein; Blotting, Western; Boronic Acids; Bortezomib; Carcinoma; Carcinoma, Medullary; Cell Line, Tumor; Colorimetry; Doxorubicin; Genes, bcl-2; Humans; Membrane Potentials; Oncogene Protein v-akt; Protease Inhibitors; Pyrazines; RNA, Neoplasm; Tetrazolium Salts; Thiazoles; Thyroid Neoplasms; Transcription, Genetic

2007
[Chemosensitivity test for thyroid cancer by in vitro MTT assay].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1995, Volume: 22, Issue:12

    Topics: Antineoplastic Agents; Cisplatin; Coloring Agents; Doxorubicin; Drug Screening Assays, Antitumor; Female; Fluorouracil; Humans; Male; Middle Aged; Tetrazolium Salts; Thiazoles; Thyroid Neoplasms; Tumor Cells, Cultured

1995
[In vitro chemosensitivity test for seven undifferentiated thyroid carcinoma cell lines using MTT assay].
    Gan to kagaku ryoho. Cancer & chemotherapy, 1996, Volume: 23, Issue:4

    Topics: Antineoplastic Agents; Bleomycin; Carcinoma; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Drug Screening Assays, Antitumor; Etoposide; Humans; Methotrexate; Tetrazolium Salts; Thiazoles; Thyroid Neoplasms; Tumor Cells, Cultured; Vincristine

1996